Clinically Translatable Cardiac Diffusion MR for Non-Contrast Characterization of View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2014-2015

FUNDING AMOUNT

28486 USD

ABSTRACT

DESCRIPTION (provided by applicant): The long-term objective is to develop an innovative and clinically robust cardiac diffusion MRI sequence that is sensitive to changes to myocardial tissue microstructure. The ability to characterize myocardial tissue microstructure will allow for unique insight to the pathophysiological progression of cardiovascular diseases (CVD) such as acute coronary syndrome, myocarditis, and cardiomyopathy, which are among the leading causes of morbidity and mortality of the US. Conventional cardiac MRI (CMR) techniques have shown to be clinically valuable in revealing morphological changes in the myocardium while providing excellent soft tissue contrast. However, validated CMR techniques used for myocardial tissue characterization require the use contrast agents. For patients with compromised renal systems such as those with Chronic Kidney Disease (CKD), these patients cannot benefit from these contrast-based techniques. Furthermore, 25% of CKD patients have a severe form of CVD that results in left ventricular hypertrophy (LVH) and can directly benefit from characterization of myocardial tissue fibrosis. Therefore, there is a need for a novel MR technique capable of non- contrast quantification of myocardial fibrosis, which we believe can be achieved with cardiac diffusion MRI. In this proposed project, a clinically translatable cardiac diffusion MR technique capable of myocardial fibrosis characterization of the human myocardium will be applied in hypertrophic cardiomyopathy patients (HCM) who are known to have high degree of fibrosis validated with contrast-enhanced CMR. Specific Aim 1 addresses the technical challenges of the clinical translation of a newly established cardiac diffusion MR technique developed by our lab, which requires better spatial coverage, spatial resolution, and shorter scan times. Specific Aim 2 will apply the proposed technique developed in Specific Aim 1 to HCM patients to characterize the extent of myocardial fibrosis and compare it with validated contrast-enhanced CMR methods. Hypothesis: Clinical translation of cardiac diffusion MRI requires major technical innovation, and a key application to demonstrate the technique's clinical utility for CKD+LVH patients would be to characterize myocardial fibrosis in HCM patients without the use of contrast agents. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=8784942

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": "28486"
    }, 
    "description": "DESCRIPTION (provided by applicant): The long-term objective is to develop an innovative and clinically robust cardiac diffusion MRI sequence that is sensitive to changes to myocardial tissue microstructure. The ability to characterize myocardial tissue microstructure will allow for unique insight to the pathophysiological progression of cardiovascular diseases (CVD) such as acute coronary syndrome, myocarditis, and cardiomyopathy, which are among the leading causes of morbidity and mortality of the US. Conventional cardiac MRI (CMR) techniques have shown to be clinically valuable in revealing morphological changes in the myocardium while providing excellent soft tissue contrast. However, validated CMR techniques used for myocardial tissue characterization require the use contrast agents. For patients with compromised renal systems such as those with Chronic Kidney Disease (CKD), these patients cannot benefit from these contrast-based techniques. Furthermore, 25% of CKD patients have a severe form of CVD that results in left ventricular hypertrophy (LVH) and can directly benefit from characterization of myocardial tissue fibrosis. Therefore, there is a need for a novel MR technique capable of non- contrast quantification of myocardial fibrosis, which we believe can be achieved with cardiac diffusion MRI. In this proposed project, a clinically translatable cardiac diffusion MR technique capable of myocardial fibrosis characterization of the human myocardium will be applied in hypertrophic cardiomyopathy patients (HCM) who are known to have high degree of fibrosis validated with contrast-enhanced CMR. Specific Aim 1 addresses the technical challenges of the clinical translation of a newly established cardiac diffusion MR technique developed by our lab, which requires better spatial coverage, spatial resolution, and shorter scan times. Specific Aim 2 will apply the proposed technique developed in Specific Aim 1 to HCM patients to characterize the extent of myocardial fibrosis and compare it with validated contrast-enhanced CMR methods. Hypothesis: Clinical translation of cardiac diffusion MRI requires major technical innovation, and a key application to demonstrate the technique's clinical utility for CKD+LVH patients would be to characterize myocardial fibrosis in HCM patients without the use of contrast agents.", 
    "endDate": "2015-06-15T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.280347.a", 
      "type": "Organization"
    }, 
    "id": "sg:grant.3801990", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "3801990"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "F31EB018152"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "unique insights", 
      "clinical utility", 
      "high degree", 
      "myocardium", 
      "CKD+LVH patients", 
      "Clinically Translatable Cardiac Diffusion MR", 
      "morbidity", 
      "mortality", 
      "conventional cardiac MRI", 
      "changes", 
      "myocardial fibrosis", 
      "contrast", 
      "hypothesis", 
      "good spatial coverage", 
      "CMR methods", 
      "CMR techniques", 
      "LVH", 
      "human myocardium", 
      "ability", 
      "cardiac diffusion MRI", 
      "Non-Contrast Characterization", 
      "technical challenges", 
      "technique", 
      "key applications", 
      "clinical translation", 
      "spatial resolution", 
      "major technical innovations", 
      "cause", 
      "applicants", 
      "acute coronary syndrome", 
      "use contrast agents", 
      "description", 
      "patients", 
      "extent", 
      "long-term objective", 
      "fibrosis", 
      "myocardial tissue microstructure", 
      "myocardial tissue characterization", 
      "translatable cardiac diffusion MR technique", 
      "lab", 
      "CKD patients", 
      "hypertrophic cardiomyopathy patients", 
      "contrast agent", 
      "characterization", 
      "cardiac diffusion MR technique", 
      "Specific Aim 1", 
      "novel MR techniques", 
      "pathophysiological progression", 
      "robust cardiac diffusion MRI sequence", 
      "project", 
      "myocardial fibrosis characterization", 
      "US", 
      "morphological changes", 
      "Specific Aim 2", 
      "myocarditis", 
      "severe form", 
      "cardiovascular disease", 
      "non- contrast quantification", 
      "myocardial tissue fibrosis", 
      "cardiomyopathy", 
      "HCM patients", 
      "use", 
      "need", 
      "excellent soft tissue contrast", 
      "short scan time", 
      "ventricular hypertrophy", 
      "chronic kidney disease", 
      "renal system"
    ], 
    "name": "Clinically Translatable Cardiac Diffusion MR for Non-Contrast Characterization of", 
    "recipient": [
      {
        "id": "https://www.grid.ac/institutes/grid.50956.3f", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/grid.50956.3f", 
          "name": "CEDARS-SINAI MEDICAL CENTER", 
          "type": "Organization"
        }, 
        "familyName": "NGUYEN", 
        "givenName": "CHRISTOPHER T", 
        "id": "sg:person.01331047206.43", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.01331047206.43", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.3801990"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T11:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_0.xml.gz", 
    "startDate": "2014-09-08T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=8784942"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.3801990'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.3801990'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.3801990'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.3801990'


 

This table displays all metadata directly associated to this object as RDF triples.

112 TRIPLES      19 PREDICATES      90 URIs      82 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.3801990 schema:about anzsrc-for:2211
2 schema:amount N5c5571de11ef450a957fff69c2a3ecd3
3 schema:description DESCRIPTION (provided by applicant): The long-term objective is to develop an innovative and clinically robust cardiac diffusion MRI sequence that is sensitive to changes to myocardial tissue microstructure. The ability to characterize myocardial tissue microstructure will allow for unique insight to the pathophysiological progression of cardiovascular diseases (CVD) such as acute coronary syndrome, myocarditis, and cardiomyopathy, which are among the leading causes of morbidity and mortality of the US. Conventional cardiac MRI (CMR) techniques have shown to be clinically valuable in revealing morphological changes in the myocardium while providing excellent soft tissue contrast. However, validated CMR techniques used for myocardial tissue characterization require the use contrast agents. For patients with compromised renal systems such as those with Chronic Kidney Disease (CKD), these patients cannot benefit from these contrast-based techniques. Furthermore, 25% of CKD patients have a severe form of CVD that results in left ventricular hypertrophy (LVH) and can directly benefit from characterization of myocardial tissue fibrosis. Therefore, there is a need for a novel MR technique capable of non- contrast quantification of myocardial fibrosis, which we believe can be achieved with cardiac diffusion MRI. In this proposed project, a clinically translatable cardiac diffusion MR technique capable of myocardial fibrosis characterization of the human myocardium will be applied in hypertrophic cardiomyopathy patients (HCM) who are known to have high degree of fibrosis validated with contrast-enhanced CMR. Specific Aim 1 addresses the technical challenges of the clinical translation of a newly established cardiac diffusion MR technique developed by our lab, which requires better spatial coverage, spatial resolution, and shorter scan times. Specific Aim 2 will apply the proposed technique developed in Specific Aim 1 to HCM patients to characterize the extent of myocardial fibrosis and compare it with validated contrast-enhanced CMR methods. Hypothesis: Clinical translation of cardiac diffusion MRI requires major technical innovation, and a key application to demonstrate the technique's clinical utility for CKD+LVH patients would be to characterize myocardial fibrosis in HCM patients without the use of contrast agents.
4 schema:endDate 2015-06-15T00:00:00Z
5 schema:funder https://www.grid.ac/institutes/grid.280347.a
6 schema:identifier N15690029cb7947a49350f1c3d9d1ba99
7 N479ebd73a053484180af63cc9e2dfc97
8 schema:inLanguage en
9 schema:keywords CKD patients
10 CKD+LVH patients
11 CMR methods
12 CMR techniques
13 Clinically Translatable Cardiac Diffusion MR
14 HCM patients
15 LVH
16 Non-Contrast Characterization
17 Specific Aim 1
18 Specific Aim 2
19 US
20 ability
21 acute coronary syndrome
22 applicants
23 cardiac diffusion MR technique
24 cardiac diffusion MRI
25 cardiomyopathy
26 cardiovascular disease
27 cause
28 changes
29 characterization
30 chronic kidney disease
31 clinical translation
32 clinical utility
33 contrast
34 contrast agent
35 conventional cardiac MRI
36 description
37 excellent soft tissue contrast
38 extent
39 fibrosis
40 good spatial coverage
41 high degree
42 human myocardium
43 hypertrophic cardiomyopathy patients
44 hypothesis
45 key applications
46 lab
47 long-term objective
48 major technical innovations
49 morbidity
50 morphological changes
51 mortality
52 myocardial fibrosis
53 myocardial fibrosis characterization
54 myocardial tissue characterization
55 myocardial tissue fibrosis
56 myocardial tissue microstructure
57 myocarditis
58 myocardium
59 need
60 non- contrast quantification
61 novel MR techniques
62 pathophysiological progression
63 patients
64 project
65 renal system
66 robust cardiac diffusion MRI sequence
67 severe form
68 short scan time
69 spatial resolution
70 technical challenges
71 technique
72 translatable cardiac diffusion MR technique
73 unique insights
74 use
75 use contrast agents
76 ventricular hypertrophy
77 schema:name Clinically Translatable Cardiac Diffusion MR for Non-Contrast Characterization of
78 schema:recipient N4295917bc96a4180b8665f95dd8dcaa9
79 sg:person.01331047206.43
80 https://www.grid.ac/institutes/grid.50956.3f
81 schema:sameAs https://app.dimensions.ai/details/grant/grant.3801990
82 schema:sdDatePublished 2019-03-07T11:57
83 schema:sdLicense https://scigraph.springernature.com/explorer/license/
84 schema:sdPublisher Nb6e582fe9b44454f8a723d060bb4beac
85 schema:startDate 2014-09-08T00:00:00Z
86 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=8784942
87 sgo:license sg:explorer/license/
88 sgo:sdDataset grants
89 rdf:type schema:MonetaryGrant
90 N15690029cb7947a49350f1c3d9d1ba99 schema:name nih_id
91 schema:value F31EB018152
92 rdf:type schema:PropertyValue
93 N4295917bc96a4180b8665f95dd8dcaa9 schema:member sg:person.01331047206.43
94 schema:roleName PI
95 rdf:type schema:Role
96 N479ebd73a053484180af63cc9e2dfc97 schema:name dimensions_id
97 schema:value 3801990
98 rdf:type schema:PropertyValue
99 N5c5571de11ef450a957fff69c2a3ecd3 schema:currency USD
100 schema:value 28486
101 rdf:type schema:MonetaryAmount
102 Nb6e582fe9b44454f8a723d060bb4beac schema:name Springer Nature - SN SciGraph project
103 rdf:type schema:Organization
104 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
105 rdf:type schema:DefinedTerm
106 sg:person.01331047206.43 schema:affiliation https://www.grid.ac/institutes/grid.50956.3f
107 schema:familyName NGUYEN
108 schema:givenName CHRISTOPHER T
109 rdf:type schema:Person
110 https://www.grid.ac/institutes/grid.280347.a schema:Organization
111 https://www.grid.ac/institutes/grid.50956.3f schema:name CEDARS-SINAI MEDICAL CENTER
112 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...